Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Tiotropium HandiHaler in the treatment of COPD: a safety review.

Kesten S, Celli B, Decramer M, Leimer I, Tashkin D.

Int J Chron Obstruct Pulmon Dis. 2009;4:397-409. Epub 2009 Nov 29. Review.

2.

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.

Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW, Witek T Jr.

Eur Respir J. 2002 Feb;19(2):217-24.

3.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
4.

Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis.

Halpin DM, Dahl R, Hallmann C, Mueller A, Tashkin D.

Int J Chron Obstruct Pulmon Dis. 2015 Feb 5;10:239-59. doi: 10.2147/COPD.S75146. eCollection 2015.

5.

Tiotropium Respimat inhaler and the risk of death in COPD.

Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, Dusser D, Joseph E, Kattenbeck S, Koenen-Bergmann M, Pledger G, Calverley P; TIOSPIR Investigators.

N Engl J Med. 2013 Oct 17;369(16):1491-501. doi: 10.1056/NEJMoa1303342. Epub 2013 Aug 30.

6.

Tiotropium reduces risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trials.

Cooper CB, Anzueto A, Decramer M, Celli B, Tashkin DP, Leimer I, Kesten S.

Int J Chron Obstruct Pulmon Dis. 2011;6:269-75. doi: 10.2147/COPD.S17864. Epub 2011 May 9.

7.
8.

Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease.

ZuWallack AR, ZuWallack RL.

Expert Opin Pharmacother. 2004 Aug;5(8):1827-35. Review. Erratum in: Expert Opin Pharmacother. 2004 Sep;5(9):2051.

PMID:
15264997
9.

Safety and efficacy of the once-daily anticholinergic BEA2180 compared with tiotropium in patients with COPD.

Abrahams R, Moroni-Zentgraf P, Ramsdell J, Schmidt H, Joseph E, Karpel J.

Respir Med. 2013 Jun;107(6):854-62. doi: 10.1016/j.rmed.2013.02.005. Epub 2013 Mar 13.

10.

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial.

Niewoehner DE, Rice K, Cote C, Paulson D, Cooper JA Jr, Korducki L, Cassino C, Kesten S.

Ann Intern Med. 2005 Sep 6;143(5):317-26.

PMID:
16144890
11.

Cardiovascular safety of tiotropium in patients with COPD.

Celli B, Decramer M, Leimer I, Vogel U, Kesten S, Tashkin DP.

Chest. 2010 Jan;137(1):20-30. doi: 10.1378/chest.09-0011. Epub 2009 Jul 10.

PMID:
19592475
13.

[The efficacy and safety of low-dose tiotropium bromide inhaled via Respimat® in patients with chronic obstructive pulmonary disease].

Ma J, Zhou Z, Tang Y, Zhong N.

Zhonghua Nei Ke Za Zhi. 2014 Dec;53(12):964-8. Chinese.

PMID:
25623564
14.

A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD.

Hilleman DE, Malesker MA, Morrow LE, Schuller D.

Int J Chron Obstruct Pulmon Dis. 2009;4:253-63. Epub 2009 Jul 20. Review.

15.

[Experimental inhalation therapy with nebulized tiotropium in COPD patients unable to use the Handihaler].

Yoshizawa T, Iwashiro M, Yoshizawa A.

Nihon Kokyuki Gakkai Zasshi. 2010 Sep;48(9):649-53. Japanese.

PMID:
20954365
16.

Efficacy of tiotropium inhalation powder in african-american patients with chronic obstructive pulmonary disease.

Criner GJ, Sharafkhaneh A, Player R, Conoscenti CS, Johnson P, Keyser MT, Cassino C.

COPD. 2008 Feb;5(1):35-41. doi: 10.1080/15412550701815981.

PMID:
18259973
17.

The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients.

van Noord JA, Cornelissen PJ, Aumann JL, Platz J, Mueller A, Fogarty C.

Respir Med. 2009 Jan;103(1):22-9. doi: 10.1016/j.rmed.2008.10.002. Epub 2008 Nov 20.

18.

Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease.

Calverley PM, Lee A, Towse L, van Noord J, Witek TJ, Kelsen S.

Thorax. 2003 Oct;58(10):855-60.

19.
20.

A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.

Voshaar T, Lapidus R, Maleki-Yazdi R, Timmer W, Rubin E, Lowe L, Bateman E.

Respir Med. 2008 Jan;102(1):32-41. Epub 2007 Nov 8.

Supplemental Content

Support Center